key: cord-0756573-23h9mofx
authors: Bakaloudi, Dimitra Rafailia; Chourdakis, Michail
title: A critical update on the role of mild and serious vitamin D deficiency prevalence and the COVID-19 epidemic in Europe
date: 2021-07-30
journal: Nutrition
DOI: 10.1016/j.nut.2021.111441
sha: 08bd8f24141ee8d3f8122ffe1fea2f2aeae473c9
doc_id: 756573
cord_uid: 23h9mofx

Objective: Coronavirus disease 2019 (COVID-19) has emerged as a pandemic, affecting nearly 180 million people worldwide as of June 22(nd), 2021. In previous studies, the association between the mean Vitamin D (Vit D) concentration of each country and COVID-19 infection and mortality rate in European countries was examined. The aim of this study was to critically evaluate the relationship between Vit D mild and severe deficiency prevalence in each country and COVID-19 infection, recovery, and mortality using updated data and a different methodological approach. Research Methods & Procedures: Information on Vit D concentration/deficiency for each country was retrieved through literature search. As of June 22(nd), 2021, COVID-19 infections and mortalities per one million population as well as total recoveries were obtained. The association between Vit D deficiency and COVID-19 infection, recovery, and mortality were explored using correlation coefficients and scatterplots. Results: Non-significant correlations were observed between the number of COVID-19 infections (r=0.363; p=0.116), and recoveries (r=0.388, p=0.091) with the prevalence of mild Vit D deficiency (<50 nmol/L). Similarly, non-significant correlations were observed between COVID-19 infections (r=0.215, p=0.392) and recoveries (r=0.242, p=0.332) with the prevalence of severe Vit deficiency (<30 nmol/L). Significant correlations were found between COVID-19 mortality and prevalence of both mild Vit D deficiency (<50 nmol/L), (r=0.634, p=0.003) and severe Vit D deficiency (<30 nmol/L) (r=0.538, p=0.021 and COVID-19 mortality rates. Conclusions: Prevalence of both mild and severe Vit D deficiency was not associated with the number of infections of COVID-19 among European countries. Thus, it is an important parameter to be considered when implementing preventive measures to face COVID-19.

COVID-19 has become a global public health emergency, affecting more than 180 million people from 222 countries and territories [1] in less than a year since the very first outbreak in Wuhan, China [2] . As of June 22 nd , 2021, the lowest and highest number of confirmed cases were reported in Oceania (~70000) and

Europe (~47.500.000) [1] . This substantial variation in the number of infections and as well as the severity and mortality of the disease can be accredited to several factors, both at the state level as well as at an individual level. "State level" parameters include diverse factors, such as a country's preparedness, actions of the governments, health infrastructure, timing of lockdown, rapid border closures, implementation of social distancing and socioeconomic status [3] , while the "individual level" includes the sociodemographic factors and other determinants of health status such as sex, age, chronic diseases, obesity, and malnutrition [4, 5] .

It is well known that malnutrition constitutes a risk factor for increased mortality and morbidity of several diseases [6] . Protein and energy malnutrition, and other specific micronutrient deficiencies have been shown to manifest adverse effects in immunity and thereby exhibit poor prognosis of viral infections [7] .

Regarding micronutrients, the association between vitamin D (Vit D) deficiency and various diseases' prevalence and/or severity, such as autoimmune disorders, diabetes, skeletal diseases, and acute respiratory tract infections have been adequately established in the past years [8, 9] . However, evidence with regards to Vit D concentration and preventive and/or curative mechanisms of SARS-CoV-2 infection are limited [10] or present some controversies [11] [12] [13] . Recent studies have demonstrated the mechanisms for possible interactions between serum vitamin D concentration and rate of COVID-19 infections [14] . Particularly, Vit D modulates the expression of angiotensin-converting enzyme 2 (ACE2), angiotensin (1-7) (Ang (1-7)), and Mas receptor (MasR) axis and plays a crucial role in the protection against lung infection [15] [16] [17] . Thereby it acts as a renin-angiotensin system (RAS) inhibitor in treating COVID-19 patients with underlying comorbidities [18, 19] and can lead to a weakening of the cytokine storm and the Acute Respiratory Syndrome (ARS) risk among COVID-19 patients, but all this evidence lacking clinical validation [20, 21] .

In three recently published studies the relationship between mean concentration of Vit D and number of cases and deaths of COVID-19/1M population in 20 European countries, negative correlations were reported [10, 22, 23] . In this study we aimed to critically evaluate the relationship between the status of Vit D and infections, recoveries, and mortalities of COVID-19 in European countries, using more recent data and a different methodological approach. Moreover, we also examined the relationship between severe Vit D deficiency (<30 nmol/L) and COVID-19 infections, recoveries and mortalities.

Information on COVID-19 infections, recoveries and mortalities, were retrieved from the Worldometer website, which provides real time statistics [1] . This source contains data derived directly from official government reports of individual countries and/or indirectly through reliable local media resources.

Data on the prevalence of Vit D deficiency among these countries were extracted by conducting a comprehensive electronic search in PubMed ® database (up to June 23 rd 2021). An advanced search was performed at the level of title/abstract by using keywords such as "Vitamin D" or "25-hydroxyvitamin D 3 ", combined with "deficiency", "prevalence" or "status" and the name of each European country. The final search string for each country and additional information about our search strategy are presented in Supplementary Table 1 .

Inclusion criteria for our study were: a) Population-based studies that reported data including the 2010

year; b) Studies reporting non-institutional adults (≥18 years old); c) Studies defining Vit D mild deficiency as serum concentration <20 ng/ml or <50 nmol/l and/or severe deficiency as <12 ng/ml or <30 nmol/l ; d) Studies reporting Vit D deficiency prevalence of the sample population; e) European countries with population >1M; f) European countries in which >60.000 COVID-19 test/1M population were performed. Editorials, commentaries, book chapters/book reviews and studies confined to selective sample of community-dwelling people, such as pregnant women, menopausal women and patients with diagnosed illnesses were excluded. As a last step, out of the screened articles for each country, the prevalence of Vit D deficiency data was retrieved from the most recently published study, (completion of the measurements not earlier than 2010), including the most representative sample for each country.

For each European country, information on COVID-19 infections, recoveries and mortalities per 1M population as of June, 22 nd 2021, were extracted from the Worldometer website [1] . From the selected articles reporting Vit D deficiency among these countries, name of the first author, published year, sample size, age range of the study population, mean Vit D concentration (nmol/L) and prevalence (%) of Vit D mild and severe deficiency were retrieved. All data were extracted by one reviewer (DB) using a standardized excel form and were checked for accuracy by a second reviewer (MC).

The relationship between the prevalence of Vit D deficiency and variables, such as number of COVID-19 infections, recoveries, and mortalities per 1M population were explored with Pearson (r) correlation coefficients due to the normally distributed data. Scatter plots were used to visually represent the correlations. All countries were represented by a 3-letter country code according to the ISO (International Organization for Standardization) 3166, as per the Terminology Bulletin Country Names and the Country and Region Codes for Statistical Use maintained by the United Nations Statistics Divisions [24] . Pearson's correlation (2-tailed) tests were performed using the IBM SPSS ® version 25.0 software.

A total of 20 European countries, satisfying the inclusion/exclusion criteria were selected for the analysis [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] part of our analysis because of the absence or non-updated evidence regarding Vit D concentration or due to a non-representative sample. The prevalence of Vit D deficiency (<50 nmol/l) ranged from 6.9-75.8% with the lowest and highest rates reported in Finland [30] , and Bulgaria [28] respectively. The prevalence of Vit D severe deficiency (<30 nmol/l) ranged from 0.9% in Finland [30] to 30.2% in Germany [32] . In nine of the countries, the majority (>50%) of the adult population studied was Vit D deficient (i.e. <20 ng/ml or <50 nmol/l) [27, 28, 32, 33, 37, 38, 40, 42, 44] . The size of study population which was used to retrieve data for the prevalence of Vit D deficiency varied from 280 (Slovenia) [40] to 74235 subjects (Italy) [35] . (Figure 1) . A non-significant correlation, (r=0.215; p=0.392), was also observed between COVID-19 infections and severe Vit D deficiency (<30 nmol/l) ( Figure 2 ). Figure 3 , COVID-19 mortality per 1M population was correlated with the prevalence of Vit D deficiency (<50 nmol/l) (r=0.634; p=0.003) and similarly, a positive correlation was found between the prevalence of severe Vit D deficiency (<30 nmol/l), (r=0.538, p=0.021) and COVID-19 mortality rates, as can be seen in Figure 4 .

As per the recovered COVID-19 cases per 1M population, non-significant correlations with the prevalence of both Vit D deficiency and severe deficiency can be observed in Supplementary File 1 (r=0.388,   p=0 .091) and (r=0.242, p=0.332) respectively.

Our analysis concluded that available data on the prevalence of Vit D deficiency among the European population do not allow for concluding that this constitutes a strong risk factor for the COVID-19 epidemic.

However, these findings are not in line with outcomes of similar research works published recently [10, 22, 23, 45] .

According to the outcomes of our study, in several of the European countries included in this analysis, more than 50% of the adult population was Vit D deficient, which constitutes a factor that should not be disregarded in the planning of public health preventive measures [27, 28, 32, 33, 37, 38, 40, 42, 44] . Factors that can influence Vit D concentration include the fluctuations of sunlight exposure among seasons [46] , especially the negligible amount of sunlight during winter and cloud covers during summer could potentially reduce the cutaneous synthesis of Vit D in some less south located countries [47, 48] , as well as extend of clothing coverage and sunscreen use [49, 50] . Furthermore, dietary sources of Vit D are limited and the obesity epidemic in the Europe, which is also related to poorer dietary choices, can worsen its deficiency [51] .

Additionally, vegetarianism/veganism [52] and chronic diseases such as kidney disease [53, 54] , liver disease [55] , malignancies [56] and genetic-epigenetic factors [57] can influence Vit D concentration.

The results of our analysis showed that the prevalence of Vit D deficiency and severe deficiency are not associated with COVID-19 infections. Nevertheless, the fact that our results differ from previous similar published studies [10, 22, 23] can be attributed to our alternative methodological approach, which we think is correct. In our study only prevalence of Vit D deficiency for each European country was used instead of mean Vit D concentration for each country, a parameter which was used in those other studies. A "mean" value cannot be representative of the Vit D concentration of a whole country because it is influenced by outliers and skewed populations. Therefore, we think that in the light of the most recent evidence of the COVID-19 pandemic, as well as by using more updated information on Vit D deficiency prevalence for each included country (completion of the measurements not earlier than 2010), we have been able to think that we ended up with more accurate conclusions.

We need to underline that COVID-19 mortalities seem to be correlated with the Vit D deficiency prevalence (<50 nmol/L and <30 nmol/L). However, for a variety of reasons, this is not enough to allow for a conclusion that Vit D concentration can be associated with the COVID-19 epidemic. First of all, COVID-19 infection precedes mortality, and the former which was found to be correlated neither with the prevalence of mild deficiency nor of severe deficiency. Moreover, underline conditions, such as diabetes mellitus, cancer, cardiovascular diseases, autoimmune disorders, infectious disease, etc., which are related with Vit D deficiency [58, 59] can be co-factors of COVID-19-specific mortality [60, 61] . Furthermore, recent analyses, showed that high UVA radiation exposure could be associated with lower COVID-19 specific mortality, which could consist a Vit D independent effect [62] [63] [64] .

Undoubtedly, Vit D deficiency observed in several European countries is considered to be an important factor that should be treated -frequently under medical supervision. Such a deficiency cannot be always tackled by advising for an enhanced dietary intake [65, 66] , nor should an often unjustified (over)use of Vit D supplementations be used as a method to lower the risk for COVID-19 infection.

Numerous preprints with regard to Vit D status and its association with the COVID-19 infection, recovery and mortality can be found in relevant databases (e.g., medRxiv), but these preprints have not been peer-reviewed and therefore should not be used as clinical practice guidance; additionally, such fast-track publications constitute a common risk for low quality information and should not be considered of paramount importance during the COVID-19 pandemic. An editorial in Lancet, stands equally skeptical towards findings regarding Vit D supplementation in COVID-19 patients, until more solid data become available [67] . In addition, Szeto et al examined the association between Vit D pre-hospitalized concentrations and COVID-19 clinical outcomes but data could not support any relationship [68] . Moreover, also outside the scope of COVID-19, evidence regarding associations of Vit D with any outcome seems not to be convincing despite the great number of systematic reviews and meta-analyses that have been published [69] .

According to our knowledge this is the first review in which not only the prevalence of Vit D deficiency (<50 nmol/l) but also the prevalence of severe Vit D deficiency (<30 nmol/l) was examined.

Although only 20 European countries satisfied our inclusion criteria, the analysis included a significant part of the European population [70] . Therefore, the results of our study could be generalized to most of the excluded European countries too. Moreover, along with the majority of high income countries, upper-middle income countries, such as Bosnia and Herzegovina were also included in the analysis [71] , reflecting the effect of economic status in the outcomes.

Among the limitations of our study is that the data on prevalence of Vit D deficiency of the countries included was not generated from national level surveys. Therefore, the very recently published studies with the most representative sample for each country's population were carefully selected for our analysis. As described in our Methods, screened studies were limited to adults (≥18 years), as the severity of COVID-19

infections among children has been rather mild [72] . More detailed data regarding neither COVID-19 infection rates per age nor age distribution for each country was available, and therefore correlations for these subgroups could not be performed. The fact that data of the prevalence of Vit D deficiency were not reported the same period of the COVID-19 pandemic could have an impact on the accuracy of our results. Moreover, seasonal values for Vit D concentrations were not available in the majority of the included studies and therefore only annual averaged rates were used.

Governments should implement proper preventive measures to increase awareness among the populations on the risk of Vit D deficiency rather than on its role in during the COVID-19 pandemic. Vit D supplementation should be advised only for those belonging to a high risk group of deficiency, such as newborns, toddlers, pregnant women, elderly as well as non-Western immigrants [73] , always under medical supervision and not as a preventive factor of COVID-19 infection because long term effects of such approach are unkown. There might be several on-going randomized controlled trials (RCTs) examining the Vit D supplementation in COVID-19 patients [74] , however until there are solid data available from well-designed RCTs that will allow us to take relevant clinical decisions, the supplementation of Vit D as a way to prevent infection or improve recovery cannot be evidence based suggested.

An absence of correlation was detected between the total number of COVID-19 epidemic with respect to country-specific prevalence of Vit D deficiency and severe deficiency among 20 European countries. The different methodological approach and the updated data regarding Vit D prevalence of each country included, led to different results in relation to previous published studies and this should be considered for the clinical practice.

. 

The novel coronavirus outbreak in Wuhan, China. Global health research and policy

A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes

Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overview

Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

Malnutrition is associated with increased mortality in older adults regardless of the cause of death

Enhancing immunity in viral infections, with special emphasis on COVID-19: A review

Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data

Role of vitamin D in preventing of COVID-19 infection, progression and severity

The link between vitamin D and COVID-19: distinguishing facts from fiction

Vitamin D and Covid-19: an update on evidence and potential therapeutic implications

Vitamin D supplementation and outcomes in coronavirus disease 2019 (COVID-19) patients from the outbreak area of Lombardy

Association of Vitamin D Levels, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results

Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system

Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathways

Perspective: Vitamin D deficiency and COVID-19 severity -plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. The Journal of steroid biochemistry and molecular biology

SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?

Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19

Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients

Revisiting the role of vitamin D levels in the prevention of COVID-19 infection and mortality in European countries post infections peak

The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality

ISO 3166 Country Codes. The International Standard for country codes and codes for their subdivisions: International Organization for Standardization

Vitamin D Intake and Status in Austria and Its Effects on Some Health Indicators

Vitamin D deficiency is common among adults in Wallonia (Belgium, 51°30' North): findings from the Nutrition, Environment and Cardio-Vascular Health study

Vitamin D status in Bosnia and Herzegovina: the cross-sectional epidemiological analysis

Vitamin D status in Bulgaria--winter data

Vitamin D status and prevalence of inadequacy in Croatian population. Book of Abstracts of 4th International congress of nutritionists2016

Prevalence and determinants of vitamin D deficiency and insufficiency among three immigrant groups in Finland: evidence from a population-based study using standardised 25-hydroxyvitamin D data

Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study

Vitamin D status among adults in Germany--results from the German Health Interview and Examination Survey for Adults (DEGS1)

Association of serum vitamin D status with dietary intake and sun exposure in adults

Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program's potential for national nutrition and health surveys

LC-MS/MS based 25(OH)D status in a large Southern European outpatient cohort: gender-and age-specific differences

Vitamin D status in a multi-ethnic population of northern Norway: the SAMINOR 2 Clinical Survey

Prevalence of vitamin D deficiency and its predictors in the Portuguese population: a nationwide population-based study

Seasonal variation of serum vitamin D levels in Romania

Prevalence of Vitamin D deficiency in the North-West region of Russia: A cross-sectional study

Nutrihealth Study: Seasonal Variation in Vitamin D Status Among the Slovenian Adult and Elderly Population

Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor Study

The Prevalence and Determinants of Vitamin D Status in Community-Dwelling Older Adults: Results from the English Longitudinal Study of Ageing (ELSA)

Vitamin D status in adults and children in Transcarpathia

Vitamin D deficiency in primary health care users at risk in Spain. Nutricion hospitalaria

Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis. Advances in Nutrition

Impact of season and different vitamin D thresholds on prevalence of vitamin D deficiency in epidemiological cohorts-a note of caution

The role of sunlight exposure in determining the vitamin D status of the UK white adult population

Impact of high latitude, urban living and ethnicity on 25-hydroxyvitamin D status: A need for multidisciplinary action?

Effects of different dress styles on vitamin D levels in healthy young Jordanian women

The effect of sunscreen on vitamin D: a review

Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women

Intake and adequacy of the vegan diet. A systematic review of the evidence

Prevalence and influencing factors of vitamin D deficiency in chronic kidney disease: A crosssectional study

Vitamin-D deficiency is encountered in almost all egyptian stage 3-5 chronic kidney disease patients in spite of the sunny weather. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Prevalence of vitamin D deficiency in chronic liver disease. Digestive diseases and sciences

Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature

Genetic and epigenetic factors influencing vitamin D status

Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease

Vitamin D and type 1 diabetes mellitus: state of the art

Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The aging male : the official journal of the International Society for the Study of the Aging Male

Ultraviolet A radiation and COVID-19 deaths in the USA with replication studies in England and Italy

Does solar ultraviolet radiation play a role in COVID-19 infection and deaths? An environmental ecological study in Italy

Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update

Vitamin D status among Mediterranean regions

Worldwide vitamin D status

The Lancet D, Endocrinology. Vitamin D and COVID-19: why the controversy?

Vitamin D Status and COVID-19 Clinical Outcomes in Hospitalized Patients

Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials

COVID-19) Dashboard. Situation by WHO Region: World Health Organization

Covid-19: Why Germany's case fatality rate seems so low

Why is COVID-19 so mild in children?

Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society

COvid-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): study protocol for a randomized controlled trial

F: Females, M: Males, SD: Standard Deviation

Authors' contributions: Dimitra-Rafailia Bakaloudi, Michail Chourdakis: Conceptualization, Methodology, Validation Dimitra-Rafailia Bakaloudi.: Data curation, Writing-Original draft preparation. Michail Chourdakis: Supervision, Writing-Reviewing and Editing

☐ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: